Analyst Research Report Snapshot

Title:

Sun Pharmaceutical Industries Ltd.

Price:

$50.00

Provider:

MarketLine (a Datamonitor Company)

Date:

28 Apr 2015

Pages:

37

Type:

AcrobatPDF

Companies referenced:

Available for Immediate Download
Summary:

Sun Pharmaceutical Industries Ltd. - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Sun Pharmaceutical Industries Ltd. required for business and competitor intelligence needs - Intelligence on Sun Pharmaceutical Industries Ltd.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Sun Pharmaceutical Industries Ltd., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Sun Pharmaceutical Industries (Sun Pharma) is an international specialty pharmaceutical company. The company manufactures and markets a range of pharmaceutical formulations as branded generics as well as generics in United States, India and several other markets across the world. In India, the company specializes in therapy areas of psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology. The company operates in India, Europe, the United States, Bangladesh, Russia, Brazil, Peru, Venezuela and Mexico. It is headquartered in Mumbai, India, and employs around 14,000 people. The company recorded revenues of INR160,803.6 million (approximately $2,675.8 million) in the fiscal year ended March 2014, an increase of 42.3% over 2013. The company's operating profit was INR46,272.8 million (approximately $770 million) in fiscal 2014, an increase of 6% over 2013. Its net profit was INR31,414.7 million (approximately $522.7 million) in fiscal 2014, an increase of 5.3% over 2013. Reasons to Purchase: - Gain understanding of Sun Pharmaceutical Industries Ltd. the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Sun Pharmaceutical Industries Ltd. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Sun Pharmaceutical Industries Ltd. your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.